NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) (PAR-24-089)

This notice of funding opportunity (NOFO) encourages applications for institutional research career development (K12) programs that propose to support intensive, supervised research and career development experiences leading to research independence for clinician scientists (Scholars) conducting substance use and substance use disorder (SUD) research.

For this NOFO, clinician scientists may include (but are not limited to) physicians, clinical psychologists, social workers, and pharmacists. Scholars are expected to be supported for 3-4 years on consecutive 12-month appointments. Candidates selected for support as scholars must hold a doctorate and commit a minimum of 9 person months (equivalent to 75% of full-time professional effort) to conducting clinical research and career development activities associated with the proposed K12 program.

Scholars appointed through the proposed program may serve as the lead for a NIH-defined clinical trial that fulfills the NIH requirement for a minimal risk trial. A minimal risk trial is one in which the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. 

This Notice of Funding Opportunity (NOFO) allows appointment of  Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

Applicants may review the information found on the NIH Office of Extramural Research "Clinical Trial Requirements for Grants and Contracts": https://grants.nih.gov/policy/clinical- trials.htm for more details about how NIH is enhancing accountability and transparency of clinical research.